VaramirStart free · no cardSign in
INMB as of Nov 3 · 16:16 ET
INMBNasdaqBiological Products, (No Diagnostic Substances)

Inmune Bio, Inc. · Brief

Next report

139 days

Mar 22 · after closeest.Q3 FY26
Earnings

Expected move

No implied move.

Implied vs realized

8 reportsHistory
0 of 8≥ implied
avg implied
±27.7%
avg realized
±3.8%
Mar 29 '24±14.4%▼−1.96%×0.14
May 10 '24±4.0%▼−1.00%×0.25
Aug 2 '24±85.0%▼−6.49%×0.08
Nov 1 '24±29.3%▲+3.48%×0.12
Mar 27 '25±12.9%▲+1.48%×0.12
May 8 '25±9.0%▼−1.69%×0.19
Aug 7 '25±16.4%▼−8.24%×0.50
Q3 FY25±50.5%▲+5.78%×0.11
quarterimplied−85%0+85%realized×
Q3 FY25±50.5%▲+5.78%×0.11
Aug '25±16.4%▼−8.24%×0.50
May '25±9.0%▼−1.69%×0.19
Mar '25±12.9%▲+1.48%×0.12
Nov '24±29.3%▲+3.48%×0.12
Aug '24±85.0%▼−6.49%×0.08
2 older reports
May '24±4.0%▼−1.00%×0.25
Mar '24±14.4%▼−1.96%×0.14
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Mar 22 report · est.

—

Linked exposure

INMB report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 298-KMaterial agreement: 8-K Item 1.01.Source
Oct 19impliedImplied move: ±54.6% into Nov 2 earnings (Oct 19 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.